Extensions

Here's an analysis of US patent 12089889 regarding its term and related applications, based on the provided patent text and general USPTO information:

US Patent 12089889: Systems and methods for therapeutic nasal treatment using handheld device

• Publication Number: US12089889B2
• Application Number: US18/647,755
• Filing Date: 2024-04-26
• Publication Date: 2024-09-17
• Priority Date: 2020-04-09
• Anticipated Expiration Date: 2041-04-08

Patent Term Adjustments (PTA):
The standard term for a U.S. utility patent filed on or after June 8, 1995, is 20 years from the earliest U.S. non-provisional filing date in its chain of priority. In this case, the earliest priority date provided is April 9, 2020. Twenty years from this date would result in a nominal expiration date of April 9, 2040.

However, the "Anticipated expiration" listed in the patent's metadata is April 8, 2041. This difference indicates that Patent Term Adjustment (PTA) has been granted. PTA is added to the patent term to compensate for certain delays caused by the U.S. Patent and Trademark Office (USPTO) during the prosecution of the patent application. The difference of approximately one year (from April 9, 2040, to April 8, 2041) suggests a significant PTA award. Without direct access to the patent's prosecution history in USPTO Patent Center, the exact calculation of the PTA cannot be detailed.

Patent Term Extensions (PTE):
Patent Term Extensions (PTE) are available under 35 U.S.C. § 156 for patents claiming products (such as human drugs, medical devices, food additives) that require premarket regulatory approval from agencies like the FDA. The purpose of PTE is to restore some of the patent term lost during the regulatory review process. While US patent 12089889 relates to a medical device for therapeutic nasal treatment, it is not possible to confirm if a PTE has been applied for or granted without access to specific USPTO records or FDA listings (like the Orange Book or Green Book) which detail such applications and grants.

Continuation Applications, Divisional Applications, and Related Family Members:
The Google Patents entry for US12089889B2 lists "Other versions" including US20240268883A1. This is the patent application publication that corresponds to the granted patent US12089889B2, meaning they are part of the same patent family. The application number for US12089889 is US18/647,755.

The existence of a "Priority date 2020-04-09" earlier than the "Filing date 2024-04-26" of the US18/647,755 application indicates that US18/647,755 claims priority to an earlier application filed on April 9, 2020. This earlier application would be the "parent" in the priority chain. Without direct access to the USPTO's public pair or Patent Center, it's not possible to definitively classify the US18/647,755 application as a continuation, divisional, or continuation-in-part of that 2020-04-09 application. However, generally:

• A continuation application pursues additional claims to an invention disclosed in an earlier, still-pending application, using the same specification.
• A divisional application is filed when an examiner requires the original application to be restricted to one invention, allowing the applicant to pursue other inventions disclosed in the original application in separate applications.
• A continuation-in-part (CIP) application adds new material or scope to a prior application.

Projected Expiration Date:
The anticipated expiration date provided by the patent's metadata is April 8, 2041. This date reflects the nominal 20-year term from the earliest priority date (April 9, 2020) plus any awarded Patent Term Adjustments (PTA).